Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016)

Anika Therapeutics' (ANIK) quarterly Construction in Progress came in at $22.7 million in Q4 2016, up 101.3% year-on-year from $11.3 million in Q1 2016, and up 101.3% on a QoQ basis from $11.3 million in Q4 2015.

Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016) Analysis & Trends

Anika Therapeutics (ANIK) has 6 years of Construction in Progress data on file, last reported at $22.7 million in Q4 2016.

  • On a quarterly basis, Construction in Progress rose 101.3% year-over-year to $22.7 million in Q4 2016; TTM through Dec 2016 was $22.7 million, a 101.3% increase from a year earlier, with the FY2016 full-year figure at $22.7 million, up 101.3% from the prior year.
  • Construction in Progress for Q4 2016 stood at $22.7 million, up from $11.3 million in the prior quarter.
  • Over the last five years, Construction in Progress for ANIK reached as high as $22.7 million in Q4 2016 and fell as low as $42270.0 in Q4 2012.
  • Historically, Construction in Progress has averaged $6.9 million across 5 years, with a median of $559000.0 in 2014.
  • Across the five-year window, Construction in Progress slumped 99.84% in 2012 and surged 1916.82% in 2015, its largest moves.
  • Year by year, Construction in Progress stood at $42270.0 in 2012, then soared by 272.11% to $157292.0 in 2013, then surged by 255.39% to $559000.0 in 2014, then jumped by 1916.82% to $11.3 million in 2015, then soared by 101.3% to $22.7 million in 2016.
  • Per Business Quant data, the three most recent Construction in Progress figures were $22.7 million in Q4 2016, $11.3 million in Q4 2015, and $559000.0 in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Anika Therapeutics 198.50 Mn 131.71 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 22.70 Mn
Dec 31, 2015 11.27 Mn
Dec 31, 2014 559,000.00
Dec 31, 2013 157,292.00
Dec 31, 2012 42,270.00
Dec 31, 2011 27.16 Mn